Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market

Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market Prostate cancer market was valued at $2.6 billion in 2013 and it is expected to reach $8.3 million, by 2023. It is estimated that the market will grow at a CAGR of 12.4%. This growth will be driven by the label extensions of currently marketed drugs as well as the launch of nine new premium-priced therapies for the treatment of prostate cancer.

More information